[11C]Flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling? (Q48131537)

8 February 2018

title

[11C]Flumazenil PET in temporal lobe epilepsy: do we need an arterial input function or kinetic modeling? (English)

1 reference

8 February 2018

main subject

temporal lobe epilepsy

1 reference

1

1 reference

8 February 2018

David J. Brooks

6

1 reference

8 February 2018

John S. Duncan

7

1 reference

8 February 2018

Wolfgang Kelsch

Wolfgang Kelsch

4

0 references

Federico Turkheimer

Federico E Turkheimer

5

0 references

Rolf Heckemann

3

Rolf A Heckemann

1 reference

8 February 2018

Matthias Koepp

8

Matthias J Koepp

1 reference

8 February 2018

author name string

Prasan Panagoda

2

1 reference

8 February 2018

publication date

20 June 2007

1 reference

8 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

8 February 2018

volume

28

1 reference

8 February 2018

issue

1

1 reference

8 February 2018

page(s)

207-216

1 reference

8 February 2018

Image registration using a symmetric prior--in three dimensions.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Spectral analysis of dynamic PET studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Parametric images of benzodiazepine receptor concentration using a partial-saturation injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Parametric in vivo imaging of benzodiazepine receptor distribution in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

[11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Effects of metabolite correction for arterial input function on quantitative receptor images with 11C-flumazenil in clinical positron emission tomography studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

11C-flumazenil PET in neocortical epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [11C]flumazenil brain PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

Intrasubject correlation between static scan and distribution volume images for [11C]flumazenil PET

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

[11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600515

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600515

1 reference

8 February 2018

1 reference

8 February 2018